This has not been an easy year for hedge funds. The most popular hedge fund strategy, long/short equity, which usually churns out an …
In a research note released yesterday, Cannacord Genuity analyst Corey Davis reaffirmed a Buy rating on Actavis (ACT) with a price target of …
In a research report issued Thursday, Canaccord analyst Corey Davis initiated coverage with a “Buy” rating on Actavis plc (ACT) and a price target of $275.00 a share, representing a potential …
